Medtronic Guides FY24 Adj. EPS Below View: Boosts Dividend - Update

RTTNews | vor 581 Tagen
Stocktwits
Medtronic Guides FY24 Adj. EPS Below View: Boosts Dividend - Update

(RTTNews) - While reporting financial results for the fourth quarter on Thursday, medical devices maker Medtronic plc. (MDT) initiated adjusted earnings guidance for the full-year 2024, below analysts' estimates.

For fiscal 2023, the company now projects adjusted earnings in a range of $5.00 to $5.10 per share on organic revenue growth of 4.0 to 4.5 percent.

On average, 30 analysts polled by Thomson Reuters expect the company to report earnings of $5.20 per share for the quarter. Analysts' estimates typically exclude special items.

The Medtronic board of directors also approved an increase in Medtronic's cash dividend for the first quarter of fiscal year 2024, raising the quarterly amount to $0.69 per ordinary share, payable on July 14, 2023, to shareholders of record at the close of business on June 23, 2023.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Tags: MDT
Stocktwits
read more
Medtronic Files Complaint Against Axonics With US ITC For Two Patent Infringements

Medtronic Files Complaint Against Axonics With US ITC For Two Patent Infringements

Healthcare technology company Medtronic plc (MDT) announced Thursday it filed a complaint with the U.S. International Trade Commission (ITC), along with a parallel action in U.S. District Court for the District of Delaware, to block Axonics, Inc. (AXNX) from improperly importing and selling products that infringe two Medtronic patents related to the MRI compatibility of implantable medical devices.
RTTNews | vor 301 Tagen
Medtronic Boosts FY24 Outlook - Update

Medtronic Boosts FY24 Outlook - Update

While reporting financial results for the third quarter on Tuesday, medical devices maker Medtronic plc. (MDT) raised its adjusted earnings and organic revenue growth guidance for the full-year 2024, based on third quarter performance.
RTTNews | vor 310 Tagen
Medtronic Boosts FY23 Adj. EPS Outlook - Update

Medtronic Boosts FY23 Adj. EPS Outlook - Update

While reporting financial results for the third quarter on Tuesday, medical devices maker Medtronic plc. (MDT) provided its revenue growth guidance for the fourth quarter and raised adjusted earnings outlook for the full-year 2023, based on third quarter performance.
RTTNews | vor 674 Tagen
Medtronic Reiterates FY23 Outlook - Update

Medtronic Reiterates FY23 Outlook - Update

While reporting financial results for the first quarter on Tuesday, medical devices maker Medtronic plc. (MDT) reiterated its adjusted earnings and revenue growth guidance for the full-year 2023.
RTTNews | vor 856 Tagen
U.S. Dollar Advances Amid Higher Treasury Yields

U.S. Dollar Advances Amid Higher Treasury Yields

The U.S. dollar climbed against its most major counterparts in the New York session on Thursday, as treasury yields rose amid uncertainty about the Federal Reserve's interest rate path and U.S. President-elect Donald Trump's tariff threats.
RTTNews | vor 7Std 31 Minuten
Tools
Wirtschaftskalender
Market Hours
Interest Rates
Holidays Calendar
Forex-Markt
Forex-Volatilität
Forex-Korrelation
Forex-Nachrichten
forex analysis
COT-Daten
Liquidität
Forex-Rechner
Forex Heat-Map
Indicators Heatmap
Community
Community
Systeme
Beliebteste Systeme
Strategien
Wettbewerbe
Forex-Charts
Forex-Sentiment
Prognoseindikator
Bewertungen
Broker
Prop Trading Firms
VPS-Dienste
Signalanbieter
EA Programmierdienstleistungen
Affiliate Programs
PAMM - Broker-Dienstleistungen
Rabattprogramm-Dienstleistungen
Handelsplattformen
Expertenberater
Krypto-Börsen
Trading Courses
Broker
Forex-Spreads
Forex-Broker-Kotierungen
Forex-Broker-Swaps
Volumen des Forex-Brokers
Forex-Broker-Aktionen Broker News
Plattform
Widgets
Funktionen
API
RSS
Stock Portfolio
Affiliate Software
Erweiterte Charts
Betreuung
FAQ
Hilfe
Kontaktieren Sie uns
Fehler melden!
Über uns
Blog
© 2024 Myfxbook Ltd. Alle Rechte vorbehalten.
WARNUNG VOR HOHEM RISIKO: Der Devisenhandel birgt ein hohes Risiko, das möglicherweise nicht für alle Anleger geeignet ist. Der Einsatz von Leverage schafft zusätzliches Risiko und Verlustgefahr. Bevor Sie sich für den Devisenhandel entscheiden, sollten Sie Ihre Anlageziele, Ihr Erfahrungsniveau und Ihre Risikotoleranz sorgfältig prüfen. Sie könnten Ihre ursprüngliche Investition teilweise oder ganz verlieren. Investieren Sie kein Geld, das Sie sich nicht leisten können, zu verlieren. Informieren Sie sich über die mit dem Devisenhandel verbundenen Risiken und lassen Sie sich von einem unabhängigen Finanz- oder Steuerberater beraten, wenn Sie Fragen haben. Alle Daten und Informationen werden ausschließlich zu Informationszwecken bereitgestellt und sind nicht für Handelszwecke oder Beratung gedacht. Die vergangene Performance ist kein Indikator für zukünftige Ergebnisse.